845 related articles for article (PubMed ID: 25500120)
1. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.
Mah L; Binns MA; Steffens DC;
Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120
[TBL] [Abstract][Full Text] [Related]
2. Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia.
Sacuiu S; Insel PS; Mueller S; Tosun D; Mattsson N; Jack CR; DeCarli C; Petersen R; Aisen PS; Weiner MW; Mackin RS;
Am J Geriatr Psychiatry; 2016 Feb; 24(2):126-35. PubMed ID: 26238228
[TBL] [Abstract][Full Text] [Related]
3. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
Yu P; Dean RA; Hall SD; Qi Y; Sethuraman G; Willis BA; Siemers ER; Martenyi F; Tauscher JT; Schwarz AJ
J Alzheimers Dis; 2012; 32(2):373-85. PubMed ID: 22796873
[TBL] [Abstract][Full Text] [Related]
4. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
He P; Qu H; Cai M; Liu W; Gu X; Ma Q
Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
[TBL] [Abstract][Full Text] [Related]
5. Volumetric brain changes in thalamus, corpus callosum and medial temporal structures: mild Alzheimer's disease compared with amnestic mild cognitive impairment.
Pedro T; Weiler M; Yasuda CL; D'Abreu A; Damasceno BP; Cendes F; Balthazar ML
Dement Geriatr Cogn Disord; 2012; 34(3-4):149-55. PubMed ID: 22986782
[TBL] [Abstract][Full Text] [Related]
6. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
[TBL] [Abstract][Full Text] [Related]
7. Microstructural white matter changes in cognitively normal individuals at risk of amnestic MCI.
Zhuang L; Sachdev PS; Trollor JN; Kochan NA; Reppermund S; Brodaty H; Wen W
Neurology; 2012 Aug; 79(8):748-54. PubMed ID: 22843270
[TBL] [Abstract][Full Text] [Related]
8. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological performance and conversion to Alzheimer's disease in early- compared to late-onset amnestic mild cognitive impairment: CREDOS study.
Ye BS; Seo SW; Lee Y; Kim SY; Choi SH; Lee YM; Kim DH; Han HJ; Na DL; Kim EJ
Dement Geriatr Cogn Disord; 2012; 34(3-4):156-66. PubMed ID: 23037957
[TBL] [Abstract][Full Text] [Related]
10. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
[TBL] [Abstract][Full Text] [Related]
11. Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions.
Lee GJ; Lu PH; Hua X; Lee S; Wu S; Nguyen K; Teng E; Leow AD; Jack CR; Toga AW; Weiner MW; Bartzokis G; Thompson PM;
Biol Psychiatry; 2012 May; 71(9):814-21. PubMed ID: 22322105
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
[TBL] [Abstract][Full Text] [Related]
13. The Uncinate Fasciculus as a Predictor of Conversion from Amnestic Mild Cognitive Impairment to Alzheimer Disease.
Hiyoshi-Taniguchi K; Oishi N; Namiki C; Miyata J; Murai T; Cichocki A; Fukuyama H
J Neuroimaging; 2015; 25(5):748-53. PubMed ID: 25491469
[TBL] [Abstract][Full Text] [Related]
14. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
[TBL] [Abstract][Full Text] [Related]
15. Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression.
Joko T; Washizuka S; Sasayama D; Inuzuka S; Ogihara T; Yasaki T; Hagiwara T; Sugiyama N; Takahashi T; Kaneko T; Hanihara T; Amano N
Psychogeriatrics; 2016 Nov; 16(6):355-361. PubMed ID: 26756596
[TBL] [Abstract][Full Text] [Related]
16. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
[TBL] [Abstract][Full Text] [Related]
17. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
[TBL] [Abstract][Full Text] [Related]
18. Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment.
Sheng C; Xia M; Yu H; Huang Y; Lu Y; Liu F; He Y; Han Y
PLoS One; 2017; 12(6):e0179823. PubMed ID: 28650994
[TBL] [Abstract][Full Text] [Related]
19. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
[TBL] [Abstract][Full Text] [Related]
20. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment.
Whitwell JL; Shiung MM; Przybelski SA; Weigand SD; Knopman DS; Boeve BF; Petersen RC; Jack CR
Neurology; 2008 Feb; 70(7):512-20. PubMed ID: 17898323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
